Global Avastin Biosimilar Market Research Report 2023

Avastin Biosimilar Market

Avastin Biosimilar is a humanized monoclonal antibody. It inhibits angiogenesis (the formation of new blood vessels) by blocking the action of vascular endothelial growth factor A (VEGF-A). Bevacizumab can therefore slow the growth of new blood vessels in tumours and is used to treat various cancers, including colorectal, lung, breast, glioblastoma, kidney and ovarian.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Avastin Biosimilar market research.

Key manufacturers engaged in the Avastin Biosimilar industry include Celltrion, Amneal, Pfizer and Amgen, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Avastin Biosimilar were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Avastin Biosimilar market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Avastin Biosimilar market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Avastin Biosimilar Market Report

1.1 Product Overview and Scope of Avastin Biosimilar

1.2 Avastin Biosimilar Segment by Type

1.2.1 Global Avastin Biosimilar Market Value Comparison by Type (2023-2029)

1.2.2 400mg

1.2.3 100mg

1.3 Avastin Biosimilar Segment by Application

1.3.1 Global Avastin Biosimilar Market Value by Application: (2023-2029)

1.3.2 Cancer

1.3.3 Wet Age-related Macular Degeneration

1.3.4 Other

1.4 Global Avastin Biosimilar Market Size Estimates and Forecasts

1.4.1 Global Avastin Biosimilar Revenue 2018-2029

1.4.2 Global Avastin Biosimilar Sales 2018-2029

1.4.3 Global Avastin Biosimilar Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Avastin Biosimilar Sales Market Share by Manufacturers (2018-2023)

2.2 Global Avastin Biosimilar Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Avastin Biosimilar Average Price by Manufacturers (2018-2023)

2.4 Global Avastin Biosimilar Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Avastin Biosimilar, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Avastin Biosimilar, Product Type & Application

2.7 Avastin Biosimilar Market Competitive Situation and Trends

2.7.1 Avastin Biosimilar Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Avastin Biosimilar Players Market Share by Revenue

2.7.3 Global Avastin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Avastin Biosimilar Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Avastin Biosimilar Global Avastin Biosimilar Sales by Region: 2018-2029

3.2.1 Global Avastin Biosimilar Sales by Region: 2018-2023

3.2.2 Global Avastin Biosimilar Sales by Region: 2024-2029

3.3 Global Avastin Biosimilar Global Avastin Biosimilar Revenue by Region: 2018-2029

3.3.1 Global Avastin Biosimilar Revenue by Region: 2018-2023

3.3.2 Global Avastin Biosimilar Revenue by Region: 2024-2029

3.4 North America Avastin Biosimilar Market Facts & Figures by Country

3.4.1 North America Avastin Biosimilar Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Avastin Biosimilar Sales by Country (2018-2029)

3.4.3 North America Avastin Biosimilar Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Avastin Biosimilar Market Facts & Figures by Country

3.5.1 Europe Avastin Biosimilar Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Avastin Biosimilar Sales by Country (2018-2029)

3.5.3 Europe Avastin Biosimilar Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Avastin Biosimilar Market Facts & Figures by Country

3.6.1 Asia Pacific Avastin Biosimilar Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Avastin Biosimilar Sales by Country (2018-2029)

3.6.3 Asia Pacific Avastin Biosimilar Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Avastin Biosimilar Market Facts & Figures by Country

3.7.1 Latin America Avastin Biosimilar Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Avastin Biosimilar Sales by Country (2018-2029)

3.7.3 Latin America Avastin Biosimilar Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Avastin Biosimilar Market Facts & Figures by Country

3.8.1 Middle East and Africa Avastin Biosimilar Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Avastin Biosimilar Sales by Country (2018-2029)

3.8.3 Middle East and Africa Avastin Biosimilar Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Avastin Biosimilar Sales by Type (2018-2029)

4.1.1 Global Avastin Biosimilar Sales by Type (2018-2023)

4.1.2 Global Avastin Biosimilar Sales by Type (2024-2029)

4.1.3 Global Avastin Biosimilar Sales Market Share by Type (2018-2029)

4.2 Global Avastin Biosimilar Revenue by Type (2018-2029)

4.2.1 Global Avastin Biosimilar Revenue by Type (2018-2023)

4.2.2 Global Avastin Biosimilar Revenue by Type (2024-2029)

4.2.3 Global Avastin Biosimilar Revenue Market Share by Type (2018-2029)

4.3 Global Avastin Biosimilar Price by Type (2018-2029)

5.1 Global Avastin Biosimilar Sales by Application (2018-2029)

5.1.1 Global Avastin Biosimilar Sales by Application (2018-2023)

5.1.2 Global Avastin Biosimilar Sales by Application (2024-2029)

5.1.3 Global Avastin Biosimilar Sales Market Share by Application (2018-2029)

5.2 Global Avastin Biosimilar Revenue by Application (2018-2029)

5.2.1 Global Avastin Biosimilar Revenue by Application (2018-2023)

5.2.2 Global Avastin Biosimilar Revenue by Application (2024-2029)

5.2.3 Global Avastin Biosimilar Revenue Market Share by Application (2018-2029)

5.3 Global Avastin Biosimilar Price by Application (2018-2029)

6.1 Celltrion

6.1.1 Celltrion Corporation Information

6.1.2 Celltrion Description and Business Overview

6.1.3 Celltrion Avastin Biosimilar Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Celltrion Avastin Biosimilar Product Portfolio

6.1.5 Celltrion Recent Developments/Updates

6.2 Amneal

6.2.1 Amneal Corporation Information

6.2.2 Amneal Description and Business Overview

6.2.3 Amneal Avastin Biosimilar Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Amneal Avastin Biosimilar Product Portfolio

6.2.5 Amneal Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Corporation Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Avastin Biosimilar Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Pfizer Avastin Biosimilar Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Amgen

6.4.1 Amgen Corporation Information

6.4.2 Amgen Description and Business Overview

6.4.3 Amgen Avastin Biosimilar Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Amgen Avastin Biosimilar Product Portfolio

6.4.5 Amgen Recent Developments/Updates

7.1 Avastin Biosimilar Industry Chain Analysis

7.2 Avastin Biosimilar Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Avastin Biosimilar Production Mode & Process

7.4 Avastin Biosimilar Sales and Marketing

7.4.1 Avastin Biosimilar Sales Channels

7.4.2 Avastin Biosimilar Distributors

7.5 Avastin Biosimilar Customers

8.1 Avastin Biosimilar Industry Trends

8.2 Avastin Biosimilar Market Drivers

8.3 Avastin Biosimilar Market Challenges

8.4 Avastin Biosimilar Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Avastin Biosimilar Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Avastin Biosimilar Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Avastin Biosimilar Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Avastin Biosimilar Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Avastin Biosimilar Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Avastin Biosimilar Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Avastin Biosimilar Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Avastin Biosimilar Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Avastin Biosimilar, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Avastin Biosimilar, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Avastin Biosimilar, Product Type & Application

    Table 12. Global Key Manufacturers of Avastin Biosimilar, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Avastin Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avastin Biosimilar as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Avastin Biosimilar Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Avastin Biosimilar Sales by Region (2018-2023) & (K Units)

    Table 18. Global Avastin Biosimilar Sales Market Share by Region (2018-2023)

    Table 19. Global Avastin Biosimilar Sales by Region (2024-2029) & (K Units)

    Table 20. Global Avastin Biosimilar Sales Market Share by Region (2024-2029)

    Table 21. Global Avastin Biosimilar Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Avastin Biosimilar Revenue Market Share by Region (2018-2023)

    Table 23. Global Avastin Biosimilar Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Avastin Biosimilar Revenue Market Share by Region (2024-2029)

    Table 25. North America Avastin Biosimilar Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Avastin Biosimilar Sales by Country (2018-2023) & (K Units)

    Table 27. North America Avastin Biosimilar Sales by Country (2024-2029) & (K Units)

    Table 28. North America Avastin Biosimilar Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Avastin Biosimilar Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Avastin Biosimilar Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Avastin Biosimilar Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Avastin Biosimilar Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Avastin Biosimilar Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Avastin Biosimilar Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Avastin Biosimilar Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Avastin Biosimilar Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Avastin Biosimilar Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Avastin Biosimilar Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Avastin Biosimilar Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Avastin Biosimilar Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Avastin Biosimilar Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Avastin Biosimilar Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Avastin Biosimilar Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Avastin Biosimilar Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Avastin Biosimilar Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Avastin Biosimilar Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Avastin Biosimilar Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Avastin Biosimilar Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Avastin Biosimilar Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Avastin Biosimilar Sales (K Units) by Type (2018-2023)

    Table 51. Global Avastin Biosimilar Sales (K Units) by Type (2024-2029)

    Table 52. Global Avastin Biosimilar Sales Market Share by Type (2018-2023)

    Table 53. Global Avastin Biosimilar Sales Market Share by Type (2024-2029)

    Table 54. Global Avastin Biosimilar Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Avastin Biosimilar Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Avastin Biosimilar Revenue Market Share by Type (2018-2023)

    Table 57. Global Avastin Biosimilar Revenue Market Share by Type (2024-2029)

    Table 58. Global Avastin Biosimilar Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Avastin Biosimilar Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Avastin Biosimilar Sales (K Units) by Application (2018-2023)

    Table 61. Global Avastin Biosimilar Sales (K Units) by Application (2024-2029)

    Table 62. Global Avastin Biosimilar Sales Market Share by Application (2018-2023)

    Table 63. Global Avastin Biosimilar Sales Market Share by Application (2024-2029)

    Table 64. Global Avastin Biosimilar Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Avastin Biosimilar Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Avastin Biosimilar Revenue Market Share by Application (2018-2023)

    Table 67. Global Avastin Biosimilar Revenue Market Share by Application (2024-2029)

    Table 68. Global Avastin Biosimilar Price (US$/Unit) by Application (2018-2023)

    Table 69. Global Avastin Biosimilar Price (US$/Unit) by Application (2024-2029)

    Table 70. Celltrion Corporation Information

    Table 71. Celltrion Description and Business Overview

    Table 72. Celltrion Avastin Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. Celltrion Avastin Biosimilar Product

    Table 74. Celltrion Recent Developments/Updates

    Table 75. Amneal Corporation Information

    Table 76. Amneal Description and Business Overview

    Table 77. Amneal Avastin Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. Amneal Avastin Biosimilar Product

    Table 79. Amneal Recent Developments/Updates

    Table 80. Pfizer Corporation Information

    Table 81. Pfizer Description and Business Overview

    Table 82. Pfizer Avastin Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. Pfizer Avastin Biosimilar Product

    Table 84. Pfizer Recent Developments/Updates

    Table 85. Amgen Corporation Information

    Table 86. Amgen Description and Business Overview

    Table 87. Amgen Avastin Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. Amgen Avastin Biosimilar Product

    Table 89. Amgen Recent Developments/Updates

    Table 90. Key Raw Materials Lists

    Table 91. Raw Materials Key Suppliers Lists

    Table 92. Avastin Biosimilar Distributors List

    Table 93. Avastin Biosimilar Customers List

    Table 94. Avastin Biosimilar Market Trends

    Table 95. Avastin Biosimilar Market Drivers

    Table 96. Avastin Biosimilar Market Challenges

    Table 97. Avastin Biosimilar Market Restraints

    Table 98. Research Programs/Design for This Report

    Table 99. Key Data Information from Secondary Sources

    Table 100. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Avastin Biosimilar

    Figure 2. Global Avastin Biosimilar Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Avastin Biosimilar Market Share by Type in 2022 & 2029

    Figure 4. 400mg Product Picture

    Figure 5. 100mg Product Picture

    Figure 6. Global Avastin Biosimilar Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Avastin Biosimilar Market Share by Application in 2022 & 2029

    Figure 8. Cancer

    Figure 9. Wet Age-related Macular Degeneration

    Figure 10. Other

    Figure 11. Global Avastin Biosimilar Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 12. Global Avastin Biosimilar Market Size (2018-2029) & (US$ Million)

    Figure 13. Global Avastin Biosimilar Sales (2018-2029) & (K Units)

    Figure 14. Global Avastin Biosimilar Average Price (US$/Unit) & (2018-2029)

    Figure 15. Avastin Biosimilar Report Years Considered

    Figure 16. Avastin Biosimilar Sales Share by Manufacturers in 2022

    Figure 17. Global Avastin Biosimilar Revenue Share by Manufacturers in 2022

    Figure 18. The Global 5 and 10 Largest Avastin Biosimilar Players: Market Share by Revenue in 2022

    Figure 19. Avastin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 20. Global Avastin Biosimilar Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 21. North America Avastin Biosimilar Sales Market Share by Country (2018-2029)

    Figure 22. North America Avastin Biosimilar Revenue Market Share by Country (2018-2029)

    Figure 23. United States Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Canada Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Europe Avastin Biosimilar Sales Market Share by Country (2018-2029)

    Figure 26. Europe Avastin Biosimilar Revenue Market Share by Country (2018-2029)

    Figure 27. Germany Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. France Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. U.K. Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Italy Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Russia Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Asia Pacific Avastin Biosimilar Sales Market Share by Region (2018-2029)

    Figure 33. Asia Pacific Avastin Biosimilar Revenue Market Share by Region (2018-2029)

    Figure 34. China Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Japan Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. South Korea Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. India Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Australia Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. China Taiwan Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Southeast Asia Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Latin America Avastin Biosimilar Sales Market Share by Country (2018-2029)

    Figure 42. Latin America Avastin Biosimilar Revenue Market Share by Country (2018-2029)

    Figure 43. Mexico Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Brazil Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Argentina Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Colombia Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa Avastin Biosimilar Sales Market Share by Country (2018-2029)

    Figure 48. Middle East & Africa Avastin Biosimilar Revenue Market Share by Country (2018-2029)

    Figure 49. Turkey Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Saudi Arabia Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. UAE Avastin Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Global Sales Market Share of Avastin Biosimilar by Type (2018-2029)

    Figure 53. Global Revenue Market Share of Avastin Biosimilar by Type (2018-2029)

    Figure 54. Global Avastin Biosimilar Price (US$/Unit) by Type (2018-2029)

    Figure 55. Global Sales Market Share of Avastin Biosimilar by Application (2018-2029)

    Figure 56. Global Revenue Market Share of Avastin Biosimilar by Application (2018-2029)

    Figure 57. Global Avastin Biosimilar Price (US$/Unit) by Application (2018-2029)

    Figure 58. Avastin Biosimilar Value Chain

    Figure 59. Avastin Biosimilar Production Process

    Figure 60. Channels of Distribution (Direct Vs Distribution)

    Figure 61. Distributors Profiles

    Figure 62. Bottom-up and Top-down Approaches for This Report

    Figure 63. Data Triangulation

    Figure 64. Key Executives Interviewed